Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Becher

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Heart (British Cardiac Society)|April 30, 2025
Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AFNina Becher, Andreas Metzner, Paulus Kirchhof
Cancer Cell International|April 5, 2016
The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cellsMartina Broecker-Preuss, Nina Becher-Boveleth, Stefan Müller, et al.
European Heart Journal|July 2, 2024
Atrial fibrillation burden: a new outcome predictor and therapeutic targetNina Becher, Andreas Metzner, Tobias Toennis, et al.
Journal of Translational Medicine|July 21, 2017
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viabilityMartina Broecker-Preuss, Nina Becher-Boveleth, Andreas Bockisch, et al.
Cancer Cell International|October 15, 2015
Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO)Martina Broecker-Preuss, Nina Becher-Boveleth, Susanne Gall, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2015
Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cellsMartina Broecker-Preuss, Jan Viehof, Holger Jastrow, et al.
Journal of Cancer Research and Clinical Oncology|October 28, 2021
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trialMartina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2025
The role of comorbidities on periprocedural complications and outcomes in patients with defibrillators and cardiac resynchronization therapy: insights from the German device registryNina Becher, Matthias Hochadel, Jochen Senges, et al.
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2025
[What to do with device-detected atrial fibrillation? : Executive summary of the position paper of the German Society of Cardiology]Tobias Tönnis, Nina Becher, Ralf Birkemeyer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 24, 2025
Implementation of transcutaneous ultrasound-guided axillary vein access for implantations, revisions and upgrades of cardiac implantable electronic devices in a large tertiary care centerJulius Nikorowitsch, Tahsin Üctas, Katrin Borof, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Heart (British Cardiac Society)|April 30, 2025
Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AFNina Becher, Andreas Metzner, Paulus Kirchhof
Cancer Cell International|April 5, 2016
The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cellsMartina Broecker-Preuss, Nina Becher-Boveleth, Stefan Müller, et al.
European Heart Journal|July 2, 2024
Atrial fibrillation burden: a new outcome predictor and therapeutic targetNina Becher, Andreas Metzner, Tobias Toennis, et al.
Journal of Translational Medicine|July 21, 2017
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viabilityMartina Broecker-Preuss, Nina Becher-Boveleth, Andreas Bockisch, et al.
Cancer Cell International|October 15, 2015
Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO)Martina Broecker-Preuss, Nina Becher-Boveleth, Susanne Gall, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2015
Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cellsMartina Broecker-Preuss, Jan Viehof, Holger Jastrow, et al.
Journal of Cancer Research and Clinical Oncology|October 28, 2021
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trialMartina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2025
The role of comorbidities on periprocedural complications and outcomes in patients with defibrillators and cardiac resynchronization therapy: insights from the German device registryNina Becher, Matthias Hochadel, Jochen Senges, et al.
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2025
[What to do with device-detected atrial fibrillation? : Executive summary of the position paper of the German Society of Cardiology]Tobias Tönnis, Nina Becher, Ralf Birkemeyer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 24, 2025
Implementation of transcutaneous ultrasound-guided axillary vein access for implantations, revisions and upgrades of cardiac implantable electronic devices in a large tertiary care centerJulius Nikorowitsch, Tahsin Üctas, Katrin Borof, et al.
Pageof 2